US 7514410
Hepatitis C therapies
granted A61KA61K31/7056A61K31/7064
Quick answer
US patent 7514410 (Hepatitis C therapies) held by BioCryst Pharmaceuticals, Inc. expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K31/7056, A61K31/7064, A61K31/7068, A61K38/212